Applied Cell Technology
2014
FOUNDED
PRIVATE
STATUS
1-10
EMPLOYEES
Grant
LATEST DEAL TYPE
$526K
LATEST DEAL AMOUNT
3
INVESTORS
Description
Developer and distributor of patented platform technology created to enhance cell competence. The company's patented platform technology form genetic materials to preconditioning stallion semen improves the effectiveness of cryopreservation by preserving viability and function of the spermatozoa, makes zebrafish embryos capable to survive chilled storage for 24 hours, enhances the recovery rate of motile human sperm cells after cryopreservation, enables significantly better survival of stem cells, gametes, embryos after interventions.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
- 1 Búza street
- Gyöngyös, 3200
- Hungary
+36 (1) 000 0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Applied Cell Technology’s full profile, request a free trial.
Applied Cell Technology Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Grant | 31-Dec-2015 | $526K | Completed | Startup | ||
| 2. Early Stage VC | Completed | Startup | ||||
| 1. Early Stage VC | 01-Jan-2014 | Completed | Startup |
Applied Cell Technology Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| National Research, Development and Innovation Office | Government | 000 0000 | 000000 0 | |||
| Széchenyi Equity Fund Manager | Venture Capital | Minority | 000 0000 | 000000 0 | ||
| PortfoLion | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |